Home › Cardiomyopathy › Virginia
Cardiomyopathy clinical trials in Virginia
7 studies for Cardiomyopathy are looking for participants at sites in Virginia.
Cities in Virginia
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Charlottesville
- Clinical Trial Site, Falls Church
- Clinical Trial Site, Norfolk
- and 1 more
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 16, 2026 · NCT07052903Early Screening and Treatment of Heart Complication in Sickle Cell Disease
- Inova Schar Cancer, Fairfax
- Inova Health Care Service, Falls Church
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07023666Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- INOVA Fairfax Hospital, Falls Church
- Virginia Commonwealth University, Richmond
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials
- Children's Hospital of Richmond at VCU, Richmond
RecruitingObservational study
All ages · All sexes · Updated Jul 28, 2026 · NCT07674758MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- INOVA Fairfax Hospital, Falls Church
- Virginia Commonwealth University - Department of Internal Medicine, Richmond
RecruitingPhase 3
Ages 18 to 90 · All sexes · Updated Mar 27, 2026 · NCT06128629Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
- Virginia Commonwealth University School of Medicine, Richmond
RecruitingObservational study
Ages 18 to 85 · All sexes · Updated Jan 20, 2026 · NCT00733590Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
- Virginia Commonwealth University, Richmond
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 18, 2025 · NCT06964464From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.